This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| PJSC Pharmsynthez | 0 | 0 |
| Lockshin Curtis | 0 | 0 |
| VINOGRADOV ALEXEY ANDREEVICH | 0 | 0 |
| LLC Synbio | 0 | 0 |
| PJSC Pharmsynthez By LLC SynBio, its wholly-owned subsidiary | 0 | 0 |
| Maguire Michael Scott | 0 | 0 |
| PARSLOW JAMES F | 0 | 0 |
| Borisenko Grigory G. | 0 | 0 |
| Genkin Dmitry | 0 | 0 |
| Benz Edward J. JR | 0 | 0 |
| EISENBERG JEFFREY F | 0 | 0 |
| Logal Adam | 0 | 0 |
| Maguire Michael Scott Joint ownership with Guernsey Special Purpose Trust | 0 | 0 |
| Callaway James Eric | 0 | 0 |
| DEPTULA-HICKS DARLENE M | 0 | 0 |
| 0 | 0 | |
| Dastoor Firdaus J. | 0 | 0 |
| Kornberg Roger D. | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|